Archive | Blog

RSS feed for this section

SIAPS Voices: Working for improved access to HIV treatment in Namibia

A Q&A with Greatjoy Mazibuko, SIAPS Senior Technical Manager in Namibia You’re working in Namibia, which has one of the highest prevalence rates of HIV in the world. How does this affect life in the country? The prevalence of HIV infection stood at 17.2% in 2016, which is relatively high for sub-Saharan Africa, but it’s […]

Read full story · Comments { 0 }

A Rebirth of Sierra Leone’s Pharmaceutical System

When the World Health Organization declared the Ebola epidemic over on November 7, 2015, about 40% of the 8,704 people infected had died. The country’s health system, or what was left of it after a decade of civil war that ended in 2002, was ailing, too. Some health workers had become ill or left, leaving […]

Read full story · Comments { 0 }

Rebuilding Sierra Leone’s pharmaceutical system post-Ebola

An interview with Murtada Sesay, country project director in Sierra Leone. SIAPS is working on a two-year project funded by USAID to help rebuild and strengthen the country’s pharmaceutical system following the Ebola epidemic. What’s SIAPS doing in Sierra Leone? Our systems strengthening project there was a consequence, not only of the more recent Ebola, […]

Read full story · Comments { 0 }

What’s the ROI on investing in health systems?

By Francis (Kofi) Aboagye-Nyame, SIAPS Director You can’t put a price tag on health, but we do have budgets that determine what we can spend to help countries improve theirs. At SIAPS, that means we need to look closely at the impact each dollar we spend has on achieving our goal: strengthening the management of […]

Read full story · Comments { 0 }

World Malaria Day 2017

SIAPS supports its country partners by increasing access to effective pharmaceutical products and services and by strengthening pharmaceutical governance. Eliminating stock-outs, avoiding delays, and building human resources and institutional capacity are key to defeating malaria. Below are highlights of some key projects. Building Pharmaceutical Management Capacity in South Sudan Malaria is one of the leading […]

Read full story · Comments { 0 }

SIAPS Voices Q&A: Can we vanquish malaria for good?

An interview with Andwele Mwansasu, MD, SIAPS Senior Technical Advisor What innovations in fighting malaria over the past five years have particular promise? Has there been a watershed moment? With decreasing malaria burden all over the world, a lot has been happening in the malaria world to sustain these gains. Countries are able to detect […]

Read full story · Comments { 1 }

Institutionalizing Robust Quantification Processes and Tools within Guinea’s National Malaria Control Program

By Claude Bahati, Deputy Country Project Director, SIAPS, Guinea Accurate quantification for malaria programs, which involves forecasting the quantities needed and planning for the procurement of appropriate pharmaceuticals and supplies, is essential to ensuring that patients receive a continuous supply of commodities. The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals […]

Read full story · Comments { 0 }

Introduction of new TB medicines and regimens: An opportunity to strengthen pharmaceutical systems

New medicines and regimens, such as bedaquiline, delamanid, and the newly approved short course regimen, are an exciting development given that first- and second-line TB medicines have limited efficacy and potentially serious adverse effects. With the introduction of new TB medicines and regimens, some countries may target only the minimum WHO-recommended conditions (i.e., proper patient […]

Read full story · Comments { 1 }

Improving patient safety and building stronger health systems in Georgia

TB patients on second-line treatment experience a significant number of adverse effects. Some TB medicines result in adverse effects that, if not continuously monitored, can become serious and/or permanent and may hinder patient adherence to treatment. A number of other risk factors can also impact the safety of patients taking TB medicines, including drug interactions […]

Read full story · Comments { 0 }

Introducing new TB medicines in five countries

Click on graphic to open larger version.

Read full story · Comments { 0 }